Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $81,660,525    

Indirect Value

   $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634 Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACGN Aceragen, Inc officerTitle   –       –      –    2006-03-24 3 IO $0.00 $0 I/I 0 5,590,488 -
ACGN Aceragen, Inc officerTitle   –       –      –    2006-03-24 3 IO $0.00 $0 I/I 0 674,120 -
ACGN Aceragen, Inc officerTitle   –       –      –    2006-03-24 3 IO $0.00 $0 I/I 0 1,071,416 -
ACGN Aceragen, Inc officerTitle   –       –      –    2006-03-24 3 IO $0.00 $0 I/I 0 344,016 -
GHDX Genomic Health Inc N/A   –       –      –    2006-09-07 4 B $13.42 $11,233 I/I 837 837 0.01 -
GHDX Genomic Health Inc N/A   –       –      –    2006-09-07 4 B $13.42 $158,871 I/I 11,838 170,324 0.01 -
GHDX Genomic Health Inc N/A   –       –      –    2006-09-07 4 B $13.42 $500,916 I/I 37,325 513,133 0.01 -
GHDX Genomic Health Inc N/A   –       –      –    2006-09-08 4 B $14.12 $898,488 I/I 63,408 233,732 0.01 -
GHDX Genomic Health Inc N/A   –       –      –    2006-09-08 4 B $14.12 $2,832,727 I/I 199,911 713,044 0.01 -
GHDX Genomic Health Inc N/A   –       –      –    2006-09-08 4 B $14.12 $63,496 I/I 4,481 5,318 0.01 -
SGEN Seagen Inc Director   –       •       •   2004-08-02 4 B $5.89 $63,106 I/I 10,571 10,571 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-02 4 B $5.89 $59,810 I/I 10,019 10,019 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-02 4 B $5.89 $11,999 I/I 2,010 2,010 2.17 -
SGEN Seagen Inc Director   –       •       •   2004-08-03 4 B $5.71 $73,984 I/I 12,952 22,971 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-03 4 B $5.71 $14,840 I/I 2,598 4,608 2.17 -
SGEN Seagen Inc Director   –       •       •   2004-08-03 4 B $5.71 $78,057 I/I 13,665 24,236 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-04 4 B $5.58 $87,543 I/I 15,692 38,663 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-04 4 B $5.58 $92,368 I/I 16,557 40,793 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-04 4 B $5.58 $17,562 I/I 3,148 7,756 2.17 -
SGEN Seagen Inc Director   –       •       •   2004-08-05 4 B $5.54 $96,860 I/I 17,480 58,273 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-05 4 B $5.54 $18,641 I/I 3,364 11,120 2.17 -
SGEN Seagen Inc Director   –       •       •   2004-08-05 4 B $5.54 $91,751 I/I 16,558 55,221 2.25 -
SGEN Seagen Inc Director   –       •       •   2004-08-06 4 B $5.50 $22,968 I/I 4,176 59,397 2.17 -
SGEN Seagen Inc Director   –       •       •   2004-08-06 4 B $5.50 $4,670 I/I 849 11,969 2.17 -
SGEN Seagen Inc Director   –       •       •   2004-08-06 4 B $5.50 $24,250 I/I 4,409 62,682 2.17 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us